Explain this page
Arphra AIPlain-English read on Taysha Gene Therapies, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $12.00 (+86.92%)
Candlestick · 1Y
Open in chart workstation →TSHA
6.42+37.77%H 7.03L 4.03MA50 5.20MA200 —Avg vol 2.6M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.72% | +10.88% | +16.94% | +45.91% | +16.94% | +16.73% | +160.98% | +823.21% | -75.25% | -73.32% | -73.32% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$6.42
Bid
$6.12
850 sh
Ask
$6.70
247 sh
Spread
$0.580
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
Peers
No peer list available for TSHA.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|